T. Rowe Price Associates’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$918K Buy
16,118
+648
+4% +$36.9K ﹤0.01% 2018
2025
Q1
$868K Buy
15,470
+257
+2% +$14.4K ﹤0.01% 2026
2024
Q4
$936K Sell
15,213
-7,227
-32% -$445K ﹤0.01% 1992
2024
Q3
$1.5M Sell
22,440
-1,501
-6% -$100K ﹤0.01% 1775
2024
Q2
$1.6M Buy
23,941
+1,000
+4% +$66.8K ﹤0.01% 1674
2024
Q1
$1.63M Buy
22,941
+947
+4% +$67.4K ﹤0.01% 1676
2023
Q4
$1.85M Sell
21,994
-1,979
-8% -$167K ﹤0.01% 1573
2023
Q3
$2.06M Buy
23,973
+857
+4% +$73.7K ﹤0.01% 1447
2023
Q2
$2.16M Buy
23,116
+56
+0.2% +$5.22K ﹤0.01% 1445
2023
Q1
$2.19M Buy
23,060
+22
+0.1% +$2.09K ﹤0.01% 1432
2022
Q4
$2.32M Buy
23,038
+73
+0.3% +$7.34K ﹤0.01% 1415
2022
Q3
$1.96M Sell
22,965
-341,547
-94% -$29.2M ﹤0.01% 1461
2022
Q2
$31.3M Sell
364,512
-700
-0.2% -$60.1K ﹤0.01% 1032
2022
Q1
$32.8M Buy
365,212
+22,537
+7% +$2.03M ﹤0.01% 1097
2021
Q4
$34.3M Buy
342,675
+61,290
+22% +$6.13M ﹤0.01% 1132
2021
Q3
$26.1M Sell
281,385
-245
-0.1% -$22.7K ﹤0.01% 1229
2021
Q2
$24M Buy
281,630
+1,735
+0.6% +$148K ﹤0.01% 1256
2021
Q1
$24.2M Sell
279,895
-233
-0.1% -$20.2K ﹤0.01% 1226
2020
Q4
$23.6M Sell
280,128
-19
-0% -$1.6K ﹤0.01% 1179
2020
Q3
$22.4M Sell
280,147
-13,360
-5% -$1.07M ﹤0.01% 1124
2020
Q2
$26M Sell
293,507
-5,115
-2% -$453K ﹤0.01% 1063
2020
Q1
$28.1M Sell
298,622
-20,061
-6% -$1.89M ﹤0.01% 959
2019
Q4
$34.4M Sell
318,683
-7,874
-2% -$850K ﹤0.01% 1030
2019
Q3
$31.3M Buy
326,557
+893
+0.3% +$85.6K ﹤0.01% 1019
2019
Q2
$31.2M Buy
325,664
+9,510
+3% +$910K ﹤0.01% 1033
2019
Q1
$27.9M Buy
316,154
+23,562
+8% +$2.08M ﹤0.01% 1070
2018
Q4
$24.3M Buy
292,592
+947
+0.3% +$78.7K ﹤0.01% 1087
2018
Q3
$27.5M Buy
291,645
+61
+0% +$5.75K ﹤0.01% 1114
2018
Q2
$32.1M Buy
291,584
+1,913
+0.7% +$211K ﹤0.01% 1043
2018
Q1
$28.6M Buy
289,671
+109
+0% +$10.8K ﹤0.01% 1057
2017
Q4
$23.6M Sell
289,562
-8,996
-3% -$732K ﹤0.01% 1126
2017
Q3
$22M Sell
298,558
-4,400
-1% -$324K ﹤0.01% 1139
2017
Q2
$21.9M Buy
302,958
+1,100
+0.4% +$79.6K ﹤0.01% 1142
2017
Q1
$18.8M Sell
301,858
-3,161
-1% -$197K ﹤0.01% 1186
2016
Q4
$22.2M Hold
305,019
﹤0.01% 1105
2016
Q3
$18.2M Buy
305,019
+219
+0.1% +$13.1K ﹤0.01% 1166
2016
Q2
$19.2M Buy
304,800
+600
+0.2% +$37.8K ﹤0.01% 1115
2016
Q1
$19M Buy
304,200
+900
+0.3% +$56.3K ﹤0.01% 1097
2015
Q4
$17.8M Sell
303,300
-16,140
-5% -$945K ﹤0.01% 1122
2015
Q3
$17.2M Buy
319,440
+600
+0.2% +$32.3K ﹤0.01% 1142
2015
Q2
$19M Buy
318,840
+450
+0.1% +$26.8K ﹤0.01% 1153
2015
Q1
$19.1M Buy
318,390
+850
+0.3% +$50.9K ﹤0.01% 1146
2014
Q4
$19.1M Buy
317,540
+100
+0% +$6.01K ﹤0.01% 1126
2014
Q3
$15.5M Buy
317,440
+250
+0.1% +$12.2K ﹤0.01% 1184
2014
Q2
$16.3M Buy
317,190
+31,787
+11% +$1.64M ﹤0.01% 1172
2014
Q1
$16.5M Buy
285,403
+5,247
+2% +$303K ﹤0.01% 1167
2013
Q4
$16M Buy
280,156
+37,414
+15% +$2.14M ﹤0.01% 1156
2013
Q3
$14.4M Buy
242,742
+28,926
+14% +$1.72M ﹤0.01% 1171
2013
Q2
$11.6M Buy
+213,816
New +$11.6M ﹤0.01% 1205